Alintegimod: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 1 Phase 2 1

Condition	Trials
ALK Genomic Tumor Aberrations	1
Advanced Cancer	1
Advanced Solid Tumor	1
Anaplastic Lymphoma Kinase Genomic Tumor Aberrations	1
Colorectal Cancer	1
Hepatocellular Cancer	1
Hepatocellular Carcinoma	1
Kidney Cancer	1
Lung cancer	1
MSI-High	1
Melanoma	1
Metastasis	1
Mismatch Repair Deficiency	1
NSCLC	1
Non Small Cell Lung Cancer	1

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
NCT06362369 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations

1 recruiting trial across 15 conditions.

No. For the full record, search ClinicalTrials.gov.